Atrial Fibrillation Also called: AF, Afib

Clinical Trial Finder

Many patients with atrial fibrillation are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation

Condition:   Atrial Fibrillation
Interventions:   Drug: Dabigatran Etexilate Oral Capsule;   Drug: Rivaroxaban Oral Tablet;   Drug: Edoxaban Oral Tablet;   Drug: Apixaban Oral Tablet
Sponsors:   Danish Heart Foundation;   Danish Society of Cardiology
Not yet recruiting - verified April 2017

A.Fib Emergency Department Study Atrial Fibrillation

Condition:   Atrial Fibrillation
Intervention:  
Sponsors:   Queen's University;   Cardiac Arrhythmia Network of Canada
Recruiting - verified March 2017

Clinical Investigation of the LAmbre Left Atrial Appendage Closure System

Condition:   Atrial Fibrillation
Intervention:   Device: LAA closure system
Sponsor:   Lifetech Scientific (Shenzhen) Co., Ltd.
Completed - verified April 2017

Canadian Left Atrial Appendage Closure Study

Conditions:   Left Atrial Appendage;   Non-Valvular Atrial Fibrillation
Intervention:   Device: Ultrasept LAA Closure System
Sponsor:   Cardia Inc.
Recruiting - verified April 2017

Improving Stroke Prevention in Atrial Fibrillation Through Pharmacist Prescribing

Conditions:   Atrial Fibrillation;   Stroke
Intervention:   Drug: Anticoagulants
Sponsors:   University of Alberta;   Heart and Stroke Foundation of Canada;   Canadian Stroke Prevention Intervention Network
Recruiting - verified April 2017

Left Atrial Appendage Occlusion Versus New Oral Anticoagulants for Stroke Prevention in Patients With Non-valvular Atrial Fibrillation

Condition:   Atrial Fibrillation
Interventions:   Device: left atrial appendage occlusion;   Drug: New oral anticoagulants
Sponsors:   Sejong General Hospital;   Korea University Anam Hospital;   Yonsei University;   Gachon University Gil Medical Center;   Ulsan University Hospital
Not yet recruiting - verified April 2017

STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation

Conditions:   Atrial Fibrillation;   Atrial Fibrillation New Onset
Interventions:   Device: Cryoablation;   Drug: Antiarrhythmic drug
Sponsor:   Medtronic Atrial Fibrillation Solutions
Not yet recruiting - verified April 2017

Development of a Questionnaire to Assess Patient Knowledge About Non-vitamin K Anticoagulants (NOAC)

Conditions:   Atrial Fibrillation;   Pulmonary Embolism;   Deep Vein Thrombosis
Intervention:   Behavioral: Education
Sponsors:   University Hospital, Basel, Switzerland;   University of Basel
Recruiting - verified April 2017

Vitamin C in Cardiac Surgery Patients

Condition:   Coronary Artery Bypass Graft Surgery
Intervention:   Drug: Ascorbic Acid
Sponsors:   Geisinger Clinic;   Wilkes University
Not yet recruiting - verified April 2017

Physical Therapy and Occupational Therapy After Transcatheter Aortic Valve Replacement

Condition:   Transcatheter Aortic Valve Implantation
Interventions:   Other: Post procedure daily PT and OT;   Other: PT post procedure;   Other: OT post procedure;   Other: Routine PT or OT
Sponsors:   Henry Ford Health System;   Henry Ford Hospital
Enrolling by invitation - verified April 2017

Intra- and Post- Operative Bleeding After Simple Dental Extraction in Direct Oral Anticoagulant Therapy

Conditions:   Anticoagulant-induced Bleeding;   Dental Diseases
Intervention:   Procedure: simple dental extraction
Sponsor:   University of Trieste
Recruiting - verified April 2017

Evaluation of the Intra- and Post- Operative Bleeding After Periodontal Debridement in Direct Anticoagulant Patients

Conditions:   Anticoagulant-induced Bleeding;   Periodontal Diseases
Intervention:   Procedure: periodontal debridement
Sponsor:   University of Trieste
Recruiting - verified April 2017

Proper Extent of Maze Intercaval Lesion

Condition:   Atrial Fibrillation
Intervention:  
Sponsor:   Baylor Research Institute
Not yet recruiting - verified April 2017

Estimation of Average and Beat-to-beat Heart Rate With a Novel Wrist-worn PPG Device in Surgery Patients

Condition:   Atrial Fibrillation
Intervention:  
Sponsors:   Tampere University Hospital;   PulseOn Ltd
Not yet recruiting - verified April 2017

Repetitive Activation Patterns and Focal Impulses Identification and Ablation in Persistent AF

Condition:   Persistent Atrial Fibrillation (AF)
Intervention:   Procedure: cartofinder guided ablation followed by PVI
Sponsor:   Biosense Webster, Inc.
Recruiting - verified April 2017

Patient Perceptions and Physician Assessment of Benefits and Risks of Oral Anticoagulation Due to Non-valvular AF

Conditions:   Atrial Fibrillation;   Health Literacy
Intervention:   Other: Questionnaire
Sponsor:   Medical University of Graz
Active, not recruiting - verified April 2017

Evaluation of Ablation Index and VISITAG™ (ABI-173)

Condition:   Paroxysmal Atrial Fibrillation
Intervention:   Device: RF ablation
Sponsor:   Biosense Webster, Inc.
Recruiting - verified April 2017

Comparison of Pulmonary Vein Ablation With or Without Left Atrial Posterior Wall Ablation for Persistent AF (PIVoTAL)

Conditions:   Atrial Fibrillation Chronic;   Persistent Atrial Fibrillation
Interventions:   Procedure: Cryo or RF Ablation only of Pulmonary Veins;   Procedure: Cryo or RF Ablation of Pulmonary Veins plus Ablation of the PLAW
Sponsor:   Arash Aryana, MD
Recruiting - verified April 2017

The Comparative Safety and Effectiveness of Dabigatran, Versus Rivaroxaban, and Apixaban Utilized in the Department of Defense Non-Valvular Atrial Fibrillation Patient Population: A Retrospective Database Analysis

Condition:   Atrial Fibrillation
Interventions:   Drug: Dabigatran vs. Rivaroxaban;   Drug: Dabigatran vs. Apixaban
Sponsors:   Boehringer Ingelheim;   Health ResearchTx, LLC (HRTX);   inVentiv Health Clinical (iVH);   United States Department of Defense (DOD)
Recruiting - verified April 2017

A Study to Evaluate the Safety and Effectiveness of the Left Atrial Appendage Closure Therapy Using BSJ003W

Condition:   Atrial Fibrillation Non-Rheumatic
Intervention:   Device: BSJ003W
Sponsor:   Boston Scientific Japan K.K.
Recruiting - verified April 2017

Validation of Predictors of OAC Initiation Using EMR Data

Condition:   Atrial Fibrillation
Interventions:   Drug: Dabigatran etexilate;   Drug: Warfarin
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2017

FIND CAN Trial: "CF-172"

Condition:   Persistent Atrial Fibrillation
Intervention:   Device: Ablation procedure
Sponsor:   Biosense Webster, Inc.
Recruiting - verified April 2017

Comparison Between One-stop Hybrid Ablation and Thoracoscopic Surgical Ablation for Refactory Atrial Fibrillation

Condition:   Persistent Atrial Fibrillation
Intervention:   Procedure: Hybrid ablation
Sponsor:   China National Center for Cardiovascular Diseases
Recruiting - verified April 2017

NOACs for Stroke Prevention in Patients With Atrial Fibrillation and Previous ICH

Conditions:   Atrial Fibrillation;   Intracerebral Hemorrhage
Interventions:   Drug: NOAC;   Drug: Acetylsalicylic Acid
Sponsor:   Population Health Research Institute
Recruiting - verified April 2017

Reappraisal of Atrial Fibrillation: RACE V - Work Package 5

Condition:   Atrial Fibrillation
Intervention:   Device: Implantable loop recorder
Sponsor:   Academisch Ziekenhuis Maastricht
Recruiting - verified April 2017

Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)

Condition:   Atrial Fibrillation
Interventions:   Drug: Edoxaban-based Regimen;   Drug: VKA-based Regimen
Sponsors:   Daiichi Sankyo Inc.;   Chiltern International Inc.
Recruiting - verified April 2017

Real-World Evidence of Anticoagulation Treatment In Non-Valvular Atrial Fibrillation In Italy

Condition:   Anticoagulation
Intervention:  
Sponsors:   Bristol-Myers Squibb;   Pfizer
Not yet recruiting - verified April 2017

Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Condition:   Atrial Fibrillation
Interventions:   Drug: Edoxaban;   Drug: Clopidogrel;   Drug: Prasugrel;   Drug: ticagrelor
Sponsors:   Daiichi Sankyo Inc.;   European Cardiovascular Research Institute;   Kompetenznetz Vorhofflimmern e.V.;   Chiltern International Inc.
Recruiting - verified April 2017

Xarelto Evidence in Real Life of Patients' Preference and Satisfaction Study

Condition:   Atrial Fibrillation
Intervention:   Drug: Rivaroxaban (Xarelto, BAY 59-7939)
Sponsors:   Bayer;   Janssen Research & Development, LLC
Recruiting - verified April 2017

Sub-Clinical Atrial Fibrillation Biomarker Study

Condition:   Subclinical Atrial Fibrillation
Intervention:  
Sponsors:   Ottawa Heart Institute Research Corporation;   Population Health Research Institute;   Genome Canada
Not yet recruiting - verified April 2017

ACT DiamondTemp TempeRAture-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation

Condition:   Paroxysmal Atrial Fibrillation
Intervention:   Device: Radio frequency (RF) Cardiac ablation
Sponsor:   Advanced Cardiac Therapeutics
Recruiting - verified April 2017

Predicting Development of SCAF in Device Patients

Condition:   Atrial Fibrillation
Intervention:  
Sponsors:   Ottawa Heart Institute Research Corporation;   Genome Canada
Not yet recruiting - verified April 2017

Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation With Focal Impulse and Rotor Modulation Guided Procedures

Conditions:   Persistent Atrial Fibrillation;   Paroxysmal Atrial Fibrillation
Interventions:   Procedure: Standard PVI;   Procedure: FIRM-Guided Procedure and PVI
Sponsor:   Abbott Electrophysiology
Recruiting - verified April 2017

Apixaban in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France

Condition:   Anticoagulation
Intervention:   Drug: Apixaban
Sponsor:   Bristol-Myers Squibb
Completed - verified March 2017

Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin

Condition:   Stroke, Acute
Intervention:   Device: Reveal LINQ™ Insertable Cardiac Monitor
Sponsor:   Medtronic Cardiac Rhythm and Heart Failure
Recruiting - verified April 2017

Ventricular Arrhythmias After Pulmonary Vein Isolation

Conditions:   Ventricular Arrhythmias;   Atrial Fibrillation
Intervention:  
Sponsor:   Universitätsklinikum Hamburg-Eppendorf
Recruiting - verified April 2017

Adenosine as an Adjunct to Blood Cardioplegia

Conditions:   Pathological Processes;   Cardiomyopathies
Intervention:   Drug: Adenosine
Sponsor:   Amphia Hospital
Recruiting - verified April 2017

Pulmonary Vein Reconnection Following Ablation Index-guided Ablation: a Success Evaluation

Condition:   Atrial Fibrillation
Interventions:   Device: PVI using ThermoCool® SmartTouch® Catheter;   Device: RFA ablation data comparison
Sponsors:   Liverpool Heart and Chest Hospital NHS Foundation Trust;   Biosense Webster, Inc.
Active, not recruiting - verified April 2017

AF Patient Preference Study

Condition:   Atrial Fibrillation
Interventions:   Drug: VKA: Warfarin (Waran);   Drug: NOAC: Rivaroxaban (Xarelto, BAY59-7939);   Drug: NOAC: Dabigatran etexilate;   Drug: NOAC: Apixaban;   Drug: NOAC: Edoxaban;   Drug: NOAC: Lixiana
Sponsor:   Bayer
Completed - verified April 2017

Foresight Intracardiac Echocardiography (ICE) System

Condition:   Atrial Fibrillation
Intervention:   Device: Foresight ICE System
Sponsor:   Conavi
Completed - verified April 2017

Tissue, Blood and Biomarkers to Predict Future Atrial Fibrillation

Condition:   Atrial Fibrillation
Intervention:  
Sponsor:   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Recruiting - verified April 2017

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Standard of care drugs
Sponsors:   Bayer;   Janssen Scientific Affairs, LLC
Recruiting - verified April 2017

Rate Control in Atrial Fibrillation II

Conditions:   Atrial Fibrillation;   Permanent Atrial Fibrillation
Interventions:   Drug: Metoprolol;   Drug: Diltiazem
Sponsors:   Asker & Baerum Hospital;   Vestre Viken Hospital Trust;   Helse Sor-Ost
Recruiting - verified April 2017

A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart

Condition:   Acute Coronary Syndromes
Interventions:   Drug: Apixaban;   Drug: vitamin K antagonist;   Drug: Acetylsalicylic acid;   Other: Acetylsalicylic acid placebo
Sponsors:   Bristol-Myers Squibb;   Pfizer;   Duke Clinical Research Institute
Recruiting - verified April 2017

Impact of Colchicine Therapy on Arrhythmia Recurrence After Acute Pericardial Effusion

Condition:   Pericardial Effusion
Intervention:   Drug: Colchicine
Sponsor:   Yong Seog Oh
Recruiting - verified April 2017

Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation

Conditions:   Aortic Valve Disease;   Myocardial Infarction;   Stroke;   Bleeding
Interventions:   Drug: Aspirin + clopidogrel;   Drug: Aspirin monotherapy;   Drug: OAC + clopicogrel;   Drug: OAC monotherapy
Sponsor:   St. Antonius Hospital
Recruiting - verified April 2017

The Ottawa AF Cardioversion Protocol

Condition:   Atrial Fibrillation
Intervention:   Device: Lifepak 20E Defibrillator, Licence No: 61944
Sponsor:   David Birnie
Recruiting - verified April 2017

Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study

Condition:   Persistent Atrial Fibrillation
Intervention:   Procedure: Catheter ablation
Sponsor:   Ottawa Heart Institute Research Corporation
Recruiting - verified April 2017

Clinical Benefits of Additional Complex Fractionated Atrial Electrogram Targeted Catheter Ablation for Longstanding Persistent Atrial Fibrillation

Condition:   Atrial Fibrillation
Intervention:   Procedure: atrial electrogram and liner ablation
Sponsor:   Yonsei University
Completed - verified April 2017

Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial

Conditions:   Atrial Fibrillation;   Stroke
Interventions:   Drug: Rivaroxaban;   Drug: Acetylsalicylic acid
Sponsors:   Ottawa Heart Institute Research Corporation;   Canadian Institutes of Health Research (CIHR);   Bayer;   Biotronik SE & Co. KG
Recruiting - verified April 2017

Augmented Wide Area Circumferential Catheter Ablation for Reduction of Atrial Fibrillation Recurrence

Condition:   Atrial Fibrillation
Interventions:   Procedure: Wide area circumferential catheter ablation;   Procedure: Augmented- wide area circumferential ablation procedure
Sponsor:   Ottawa Heart Institute Research Corporation
Recruiting - verified April 2017

A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation

Condition:   Paroxysmal Atrial Fibrillation
Interventions:   Drug: BMS-919373;   Drug: Placebo (Matching with BMS-919373)
Sponsor:   Bristol-Myers Squibb
Completed - verified June 2016

Validation of International Warfarin Pharmacogenetics Consortium (IWPC) Algorithm in Elderly Patients With Comorbidity

Conditions:   Atrial Fibrillation;   Thrombus Due to Heart Valve Prosthesis
Intervention:   Drug: Warfarin
Sponsors:   Second University of Naples;   Federico II University;   University of Salerno
Active, not recruiting - verified April 2017

SORT - AF Supervised Obesity Reduction Trial for AF Ablation Patients

Conditions:   Atrial Fibrillation;   Obesity;   Sleep Apnea
Interventions:   Procedure: Intervention group;   Procedure: control group
Sponsors:   Universitätsklinikum Hamburg-Eppendorf;   St. Jude Medical
Recruiting - verified April 2017

Atrial Fibrillation Prevention in Post Coronary Artery Bypass Graft Surgery With Cryoablation for Ganglionic Plexi

Conditions:   Complication of Coronary Artery Bypass Graft;   Atrial Fibrillation
Intervention:   Procedure: Two sites cryoablation
Sponsor:   Yong Seog Oh
Recruiting - verified April 2017

Essential Hypotension and Allostasis Registry

Conditions:   Blood Pressure;   Depression;   Panic Attack;   Fibromyalgia;   POTS;   Inappropriate Sinus Tachycardia;   Coronary Heart Disease;   Acute Coronary Syndrome (ACS);   Acute Myocardial Infarction (AMI);   Cerebrovascular Disease (CVD);   Transient Ischemic Attack (TIA);   Atrial Fibrillation;   Diabetes Mellitus;   Cancer;   Systolic Heart Failure;   Diastolic Heart Failure;   Chronic Fatigue Syndrome;   Syncope;   Vasovagal Syncope
Intervention:  
Sponsor:   CES University
Recruiting - verified April 2017

CONVERGE - Epi/Endo Ablation For Treatment of Persistent Atrial Fibrillation(AF)

Condition:   Persistent Atrial Fibrillation
Interventions:   Device: Convergent Procedure EPi-Sense-AF Guided Coagulation System;   Device: Endocardial Catheter Ablation
Sponsor:   AtriCure, Inc.
Recruiting - verified April 2017

Effect of Cavotricuspid Isthmus Ablation in Patients Without History of Typical Flutter During Ablation

Condition:   Paroxysmal Atrial Fibrillation
Interventions:   Procedure: cavotricuspid isthmus ablation;   Procedure: control group
Sponsor:   Yong Seog Oh
Recruiting - verified April 2017

Adenosine Effect on Persistent Pulmonary Vein Isolation Line Evaluation (APPLE Trial)

Conditions:   Atrial Fibrillation;   Persistent Common Pulmonary Vein
Intervention:   Drug: Adenosine arm
Sponsor:   Yong Seog Oh
Completed - verified April 2017

Testing the Accuracy of a Personal Heart Rhythm Monitor to Detect Prolonged Paroxysmal Atrial Fibrillation

Conditions:   Paroxysmal Atrial Fibrillation;   Stroke
Intervention:   Device: Personal Heart Rhythm Monitor
Sponsors:   University of Surrey;   Royal Surrey County Hospital NHS Foundation Trust;   Ashford and St. Peter's Hospitals NHS Trust
Withdrawn - verified April 2017

Using a Personal Heart Rhythm Monitor to Diagnose Paroxsymal Atrial Fibrillation in the Community

Conditions:   Paroxysmal Atrial Fibrillation;   Stroke
Interventions:   Device: Automated Cardiac Event Recorder;   Device: Personal Heart Rhythm Monitor
Sponsors:   University of Surrey;   Royal Surrey County Hospital NHS Foundation Trust
Completed - verified April 2017

Therapeutic Outcomes Using Contact Force Handling During Atrial Fibrillation Ablation

Condition:   Persistent Atrial Fibrillation
Intervention:   Device: ThermoCoolSmartTouch ablation catheter, Biosense Webster
Sponsors:   Southlake Regional Health Centre;   Applied Health Research Centre
Completed - verified April 2017

Does Atrial Fibrillation (AF) Termination Without Additional Ablation Influence Outcome?

Condition:   Atrial Fibrillation
Interventions:   Procedure: PVAI;   Procedure: PVAI + ablation of extraPV triggers
Sponsors:   Texas Cardiac Arrhythmia Research Foundation;   California Pacific Medical Center
Recruiting - verified October 2016

Pulmonary Vein Antrum Isolation (PVAI) Plus Isolation of Complex Fractionated Atrial Electrograms (CAFE) and Non-PV Triggers Ensure Long-term Recurrence-free Survival in Non-paroxysmal Atrial Fibrillation

Conditions:   Persistent Atrial Fibrillation;   Long-standing Persistent Atrial Fibrillation
Interventions:   Procedure: Pulmonary Vein Antrum Isolation;   Procedure: CFAE ablation;   Procedure: Isolation of non-PV triggers
Sponsors:   Texas Cardiac Arrhythmia Research Foundation;   California Pacific Medical Center
Active, not recruiting - verified October 2016

GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2017

Dabigatran Versus Warfarin Anticoagulation Before and After Catheter Ablation for the Treatment of Atrial Fibrillation

Condition:   Atrial Fibrillation
Intervention:  
Sponsors:   William Beaumont Hospitals;   University of Pennsylvania;   Johns Hopkins University;   London Health Sciences Centre
Withdrawn - verified December 2016

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).

Condition:   Severe Aortic Stenosis
Interventions:   Device: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI);   Procedure: Surgical Aortic Valve Replacement (SAVR) (Not applicable for Single Arm);   Device: Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)
Sponsor:   Medtronic Cardiovascular
Recruiting - verified April 2017

Cardiac Sarcoidosis Multi-Center Prospective Cohort

Condition:   Cardiac Sarcoidosis
Intervention:  
Sponsors:   Ottawa Heart Institute Research Corporation;   Ontario Ministry of Health and Long Term Care;   Canadian Institutes of Health Research (CIHR)
Recruiting - verified April 2017

Impact Of Different Ablation Approaches on Outcome In Coexistent Atrial Fibrillation and Flutter

Conditions:   Atrial Arrhythmia;   Quality of Life
Interventions:   Procedure: Catheter ablation;   Procedure: Catheter ablation
Sponsors:   Texas Cardiac Arrhythmia Research Foundation;   Monzino Hospital, Milan, Italy;   Ospedale dell'Angelo, Mestre, Venice, Italy;   Catholic University, Italy;   University of Rome Tor Vergata
Completed - verified July 2014

Effect of Empirical Left Atrial Appendage Isolation on Long-term Procedure Outcome in Patients With Persistent or Long-standing Persistent Atrial Fibrillation Undergoing Catheter Ablation

Condition:   Persistent Atrial Fibrillation
Interventions:   Procedure: RFCA of PV and extra-PV triggers;   Procedure: LAA isolation along with the conventional ablation strategy
Sponsor:   Texas Cardiac Arrhythmia Research Foundation
Completed - verified October 2016

Continuous Positive Airway Pressure (CPAP) in Patients With Acute Coronary Syndrome and Obstructive Sleep Apnea (OSA)

Conditions:   Acute Coronary Syndrome;   Obstructive Sleep Apnea
Interventions:   Other: Standard care;   Device: continuous positive airway pressure
Sponsors:   Sociedad Española de Neumología y Cirugía Torácica;   ResMed;   Fondo de Investigacion Sanitaria;   EsteveTeijin Healthcare;   Societat Catalana de Cardiologia;   Sociedad Madrileña de Neumologia
Recruiting - verified April 2016

Atrial Fibrillation Ablation and Autonomic Modulation Via Thorascopic Surgery

Condition:   Atrial Fibrillation
Intervention:   Procedure: Totally Thoracoscopic PV isolation
Sponsors:   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA);   Netherlands Heart Foundation
Completed - verified April 2017

30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation After a Cerebral Ischemic Event

Conditions:   Stroke;   Transient Ischemic Attack;   Atrial Fibrillation;   Atrial Flutter
Interventions:   Device: a 30-day ambulatory cardiac event monitor;   Device: 24-hour Holter
Sponsor:   Sunnybrook Health Sciences Centre
Active, not recruiting - verified April 2017

Ablation vs Amiodarone for Treatment of AFib in Patients With CHF and an ICD

Condition:   Heart Failure
Interventions:   Procedure: Atrial Fibrillation ablation;   Drug: Amiodarone
Sponsors:   Texas Cardiac Arrhythmia Research Foundation;   Casa Sollievo della Sofferenza IRCCS;   Catholic University, Italy;   Southlake Regional Health Centre;   Stanford University;   University of Kansas;   The University of Texas Medical Branch, Galveston;   University of Foggia;   Sutter Health
Active, not recruiting - verified October 2016

CardioSmart Points

Log in to Check Your Balance
and Go Shopping

Learn how to earn more CardioSmart Points